Relationship of GSTP1, RASSF1A polymorphisms and environmental agent with susceptibility to prostate cancer: A case-control study

Academic Journal of Second Military Medical University

Volumn 31, Issue 1, 2010, Pages 12-17

  Xu, Xing Xing ^a   Chang, Wen Jun ^a   Hou, Jian Guo ^b   Xu, Dan Feng ^c   Cui, Xin Gang ^c   Zhai, Yu Jia ^a,d   Wang, Guo Ping ^a   Zhang, Hong Wei ^a   Cao, Guang Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d NAVAL AERONAUTICAL AND ASTRONAUTICAL UNIVERSITY   (China)

Author keywords

Case control studies; Genetic polymorphism; GSTP1; Prostatic neoplasms; RASSF1A

Indexed keywords

GLUTATHIONE TRANSFERASE P1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BEEF; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PORK; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TEA;

EID: 76149125799     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2010.00012     Document Type: Article

References (28)

1. Chinese source
2. Mannervik B, Awasthi Y C, Board P G, Hayes J D, Di Ilio C, Ketterer B, et al. Nomenclature for human glutathione transferases[J]. Biochem J, 1992, 282(Pt1):305-306.
3. Borad P G, Webb G C, Coggan M. Isolation of ac DNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14[J]. Ann Hum Genet, 1989, 53(pt3):205-213.
4. Lee S A, Fowke J H, Lu W, Ye C, Zheng Y, Cai Q, et al. Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk[J]. Am J Clin Nutr, 2008, 87:753-760.
5. Rossini A. Rapozo D C. Soares Lima S C, Guimarāes D P, Fer-reira M A, Teixeira R, et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population[J]. Carcinogenesis, 2007, 28:2537-2542.
6. Vlaykova T, Miteva L, Gulubova M, Stanilova S. Ile105Val GSTP1 polymorphism and susceptibility to colorectal carcinoma in Bulgarian population[J]. Int J Colorectal Dis, 2007, 22: 1209-1215.
7. Sun N, Sun X, Chen B, Cheng H, Feng J, Cheng L, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol, 2010, 65:437-446.
8. Kote-Jarai Z, Easton D, Edwards S M, Jefferies S, Durocher F, Jackson R A, et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer[J]. Pharmacogenetics, 2001, 11:325-330.
9. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population[J]. Anticancer Res, 2003, 23(3C):2897-2902.
10. Srivastava D S, Mandhani A, Mittal B, Mittal R D. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India[J]. BJU Int, 2005, 95:170-173.
11. Kidd L C, Woodson K, Taylor P R, Albanes D, Virtamo J, Tangrea J A. Polymorphisms in glutathione-S-transferase genes (GST-M1 ,GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study[J]. Eur J Cancer Prev, 2003, 12:317-320.
12. Nam R K, Zhang W W, Trachtenberg J, Jewett M A, Emami M, Vesprini D, et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer[J]. Cancer Epidemiol Biomarkers Prev, 2003, 12:1429-1437.
13. Mittal R D, Mishra D K, Mandhani A. Evaluating polymorphic status of glutathione-S-transferase genes in blood and tissue samples of prostate cancer patients[J]. Asian Pac J Cancer Prev, 2006, 7:444-446.
14. Agathanggelou A, Cooper W N, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers [J]. Cancer Res, 2005, 65:3497-3508.
15. Schagdarsurengin U, Seidel C, Ulbrich E J, Kölbl H, Dittmer J, Dammann R. A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast[J]. Int J Oncol, 2005, 27:185-191.
16. Gao B, Xie X J, Huang C, Shames D S, Chen T T. Lewis C M, et al. RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers[J]. Cancer Res, 2008, 68:22-25.
17. Lichtenstein P, Holm N V, Verkasalo P K, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland[J]. N Engl J Med, 2000, 343:78-85.
18. Payne SR, Serth J, Schostak M, Kamradt J, Strauss A, Thelen P, et al. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection[J]. Prostate, 2009, 69:1257-1269.
19. Du W B, Hou J G, Wu Q, Chang W J, Zhai Y J, Lin L P. et al. Promoter region methylation analysis of glutathione S-transferase p1 gene in prostate carcinoma [J]. Acad J Sec Mil Med Univ, 2008, 29:762-767.
20. Bryzgunova O E, Morozkin E S, Yarmoschuk S V, Vlassov V V, Laktionov P P. Methylation-specific sequencing of GSTP1 gene promoter in circulating/ extracellular DNA from blood and urine of healthy donors and prostate cancer patients[J]. Ann N Y Acad Sci, 2008, 1137:222-225.
21. Chinese source
22. Mo Z, Gao Y, Cao Y, Gao F, Jian L. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review[J]. Prostate, 2009, 69:662-688.
23. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark W M, et al. Tumor susceptibility of Rassf1a knockout mice[J]. Cancer Res, 2005, 65:92-98.
24. Vos M D, Ellis C A, Bell A, Birrer M J, Clark G J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis[J]. J Biol Chem, 2000, 275:35669-35672.
25. Nock N L, Cicek M S, Li L, Liu X, Rybicki B A, Moreira A, et al. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk[J]. Carcinogenesis, 2006, 27:1842-1848.
26. Saleem M, Adhami V M, Siddiqui I A, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review[J]. Nutr Cancer, 2003, 47:13-23.
27. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, JPHC Study Group. Green tea consumption and prostate cancer risk in Japanese men: a prospective study[J]. Am J Epidemiol, 2008, 167:71-77.
28. Park O J, Surh Y J. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies[J]. Toxicol Lett, 2004, 150:43-56.